The Norwegian Institute of Food, Fisheries and Aquaculture Research (Nofima) has via a project for SalmoBreed contributed to identifying a genetic marker (QTL) that has a significant effect on the salmons resistance against pancreas disease.
In recent years pancreas disease (PD) has inflicted losses of hundreds of millions of kroner on the Norwegian aquaculture industry, and until now no good tools have existed to deal with the disease situation.
The project was carried out by the Centre for Integrative Genetics (CIGENE) at the Norwegian University of Life Sciences (UMB) under the direction of Dr. Sigbjrn Lien, in collaboration with Nofima and the Akvaforsk Genetics Center (AFGC).
Nofimas role in the project has been to prepare samples for genotyping and to carry out data analysis in collaboration with CIGENE. These samples are part of a biobank which Nofima holds for SalmoBreed.
The term QTL is an abbreviation for quantitative trait locus, a gene or chromosome region that affects a trait.